Table 1

Schedule of interventions and assessments

Study period
(16 weeks to 8 weeks postdelivery)
Study visitTrial entry/baselineAntenatal follow-upNotes reviewPostnatal follow-up
Time point20±4
weeks gestation		30±3
weeks
gestation		40+4
weeks (postdelivery)		40+8
weeks (postdelivery)
Informed consentX   
Eligibility assessmentX   
Demographics; including age, race, educationX   
Maternal demographics; including gestation, EDD and parityX   
Patient Questionnaires; including EQ-5D-5L and STAIXX X
RandomisationX   
Recording home BPSelf-Monitoring group will record and submit reading between baseline and delivery 
Recording clinic BPs  X 
Maternal and perinatal outcomes  X 
Secondary outcome data  X 
Return of BP monitor  BP monitors will be returned at/or postdelivery

  • BP, blood pressure; EDD, Estimated Delivery Date; EQ-5D-5L, EuroQoL 5 Dimensions 5 Levels; STAI, State-Trait Anxiety Inventory.